Jade Biosciences, Inc. Common Stock

JBIONASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
20.86 USD
↗ 0.38 (1.86%)AT CLOSE (11:59 AM EDT)
20.56
↘ 0.30 (1.42%)
POST MARKET (AS OF 07:54 PM EDT)
Post Market
AS OF 07:54 PM EDT
20.56
↘ 0.30 (1.42%)
🔴Market: CLOSED

Jade Biosciences, Inc. Common Stock (JBIO) trades at $20.86 per share. Technical indicators currently signal "Buy". This is driven by negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, JBIO trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jul 17, 2026.

Open?$19.88
High?$21.45
Low?$19.40
Prev. Close?$20.48
Volume?659.5K
Avg. Volume?1.4M
VWAP?$20.83
Rel. Volume?0.46x
Bid / Ask
Bid?$18.13 × 100
Ask?$23.00 × 100
Spread?$4.87
Midpoint?$20.56
Valuation & Ratios
Market Cap?1.3B
Shares Out?49.4M
Float?41.4M
Float %?83.9%
P/E Ratio?N/A
P/B Ratio?4.28
EPS?-$1.89
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
Themes
Biotech - Drug Development›Immunology & AutoimmuneBiotech - Drug Development›Rare Disease Therapeutics
Employees
55
Market Cap
1.2B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.jadebiosciences.com
Listed
2025-04-29
Address
221 CRESCENT ST.
WALTHAM, MA 02453
Phone: (781) 312-3013
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?19.70%High
Short Interest?8.1M
Days to Cover?4.9
Free Float41.4M
Avg Daily Volume1.7M
Settlement Date2026-06-30
Financial Health
Current Ratio?14.29Strong
Quick Ratio?14.29Strong
Cash Ratio?2.47Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
42
4.28FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-10.0CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-38.8%WEAK▾
ROA?
S&P
3
-36.0%WEAK▾
Cash Flow & Enterprise
FCF?$-101690000
Enterprise Value?$1.2B
Fundamentals ratios updated end of day
MarketsMoversWatchlist